Goiter screening: Difference between revisions

Jump to navigation Jump to search
Aravind Reddy Kothagadi (talk | contribs)
No edit summary
Aravind Reddy Kothagadi (talk | contribs)
Line 15: Line 15:
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
==Screening==
==Screening==
 
*Screening for Goiter includes the following approaches and progresses to the next approach based on the result of earlier screening procedure:
*There is insufficient evidence to recommend routine screening for [disease/malignancy].
**Physical exam:
OR
***Involves the assessment of the size and the extent of enlargement of the thyroid gland. If the enlargement is positive, blood tests for Free T4 and TSH are evaluated.
*According to the [guideline name], screening for [disease name] is not recommended.
**Blood Tests:
OR
***Blood tests are carried out in order to determine whether the Goiter is affecting the production of the production of the thyroid hormone.
*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
****Free thyoxine (T4)
**[Condition 1]
****Thyroid stimulating hormone (TSH)
**[Condition 2]
**Based on the results of the physical exam and blood tests, further evaluation involving the following is advised in order to rule out malignant transformation of the gland:
**[Condition 3]
***Thyroid scan
***Ultrasound
***Biopsy of thyroid cancer


==References==
==References==

Revision as of 20:45, 14 September 2017

Goiter Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Goiter from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Goiter screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Goiter screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Goiter screening

CDC on Goiter screening

Goiter screening in the news

Blogs on Goiter screening

Directions to Hospitals Treating Cushing’s disease

Risk calculators and risk factors for Goiter screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

  • Screening for Goiter includes the following approaches and progresses to the next approach based on the result of earlier screening procedure:
    • Physical exam:
      • Involves the assessment of the size and the extent of enlargement of the thyroid gland. If the enlargement is positive, blood tests for Free T4 and TSH are evaluated.
    • Blood Tests:
      • Blood tests are carried out in order to determine whether the Goiter is affecting the production of the production of the thyroid hormone.
        • Free thyoxine (T4)
        • Thyroid stimulating hormone (TSH)
    • Based on the results of the physical exam and blood tests, further evaluation involving the following is advised in order to rule out malignant transformation of the gland:
      • Thyroid scan
      • Ultrasound
      • Biopsy of thyroid cancer

References

Template:WH Template:WS